LobbyingAssociation of Women's Health Obstetric and Neonatal Nurses lobbying by quarter
Association of Women's Health Obstetric and Neonatal Nurses's latest lobbying report covers Q2 2026, at $24.3K. The four quarters Q4 2025–Q3 2026 total $41.6K. Its first report covers Q2 2022; the issues it reports most are Health Issues and Budget/Appropriations.
Association of Women's Health Obstetric and Neonatal Nurses
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $41.7K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q2 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2022 | $5,649 | 1 |
| Q3 2022 | $0 | 1 |
| Q4 2022 | $0 | 1 |
| Q1 2023 | $19.5K | 1 |
| Q2 2023 | $0 | 1 |
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 1 |
| Q1 2024 | $19.5K | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $28.3K | 1 |
| Q2 2025 | $6,083 | 1 |
| Q3 2025 | $27.7K | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $17.3K | 1 |
| Q2 2026 | $24.3K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$58.4K · 16 reports
- Budget and appropriations$58.4K · 15 reports
- Labor, antitrust and workplace$17.8K · 3 reports
- Education$13.9K · 3 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES17 reports
- SENATE16 reports
- Centers For Medicare and Medicaid Services (CMS)6 reports
- Education, Dept of2 reports
- Agency for Healthcare Research & Quality (AHRQ)1 reports
- Centers For Disease Control & Prevention (CDC)1 reports
- Environmental Protection Agency (EPA)1 reports
- Health & Human Services, Dept of (HHS)1 reports
- President of the U.S.1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseAssociation of Women's Health, Obstetric and Neonatal Nurses | $148.5K | 17 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $24.3K |
| 04/20for Q1 | In-house | $17.3K |
| 01/07for Q4 2025 | In-house | Under $5,000 |
| 25/11/18for Q3 2024 | In-house | Under $5,000 |
| 25/10/20for Q3 2025 | In-house | $27.7K |
| 25/09/15for Q1 2025 | In-house | $28.3K |
| 25/07/28for Q2 2025 | In-house | $6,083 |
| 25/01/25for Q4 2024 | In-house | Under $5,000 |
| 24/07/22for Q1 2024 | In-house | $19.5K |
| 24/07/21for Q2 2024 | In-house | Under $5,000 |
| 24/01/19for Q4 2023 | In-house | Under $5,000 |
| 23/10/20for Q3 2023 | In-house | Under $5,000 |
| 23/07/28for Q3 2022 | In-house | Under $5,000 |
| 23/07/28for Q2 2022 | In-house | $5,649 |
| 23/07/28for Q2 2022 | In-house | $18.6K |
| 23/07/21for Q2 2023 | In-house | Under $5,000 |
| 23/05/08for Q1 2023 | In-house | $19.5K |
| 23/01/23for Q4 2022 | In-house | Under $5,000 |